ONO-4053 Phase 2a study A multicenter, double-blind, randomized parallel-group study in patients with seasonal allergic rhinitis.

Trial Profile

ONO-4053 Phase 2a study A multicenter, double-blind, randomized parallel-group study in patients with seasonal allergic rhinitis.

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Apr 2017

At a glance

  • Drugs ONO 4053 (Primary) ; Pranlukast
  • Indications Seasonal allergic rhinitis
  • Focus Therapeutic Use
  • Sponsors Ono Pharmaceutical
  • Most Recent Events

    • 04 Apr 2017 Results published in the Allergy Journal.
    • 24 Feb 2017 Status changed from active, no longer recruiting to completed.
    • 17 Mar 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top